LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG: 2291)
Hong Kong
· Delayed Price · Currency is HKD
17.42
-0.78 (-4.29%)
Oct 10, 2024, 4:08 PM HKT
LEPU ScienTech Medical Technology (Shanghai) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 216.19 | 151.53 | -19.81 | 58.7 | 68.77 | 51.91 |
| Depreciation & Amortization | 21.32 | 15.7 | 14.87 | 9.81 | 6.11 | 4.72 |
| Loss (Gain) From Sale of Assets | - | - | - | - | -5.09 | -2.43 |
| Asset Writedown & Restructuring Costs | - | - | 0 | 0 | - | - |
| Loss (Gain) From Sale of Investments | -5.98 | -5.98 | 10.66 | -0.53 | -0.53 | 1.79 |
| Stock-Based Compensation | 21.05 | 21.05 | 20.51 | 17.8 | - | - |
| Other Operating Activities | -44.7 | -16.26 | 88.04 | 5.67 | -7.03 | 1.12 |
| Change in Accounts Receivable | 4.05 | 4.05 | -12.03 | 13.51 | 8.17 | -15.87 |
| Change in Inventory | -12.03 | -12.03 | -24 | -10.08 | -12.27 | -1.43 |
| Change in Accounts Payable | 3.26 | 3.26 | 7.92 | 9.25 | 4.85 | 19.58 |
| Change in Unearned Revenue | -0.53 | -0.53 | -1.66 | -0.56 | 3.14 | 0.33 |
| Change in Other Net Operating Assets | 3.46 | 3.46 | -18.96 | 1.73 | -7.02 | -5.24 |
| Operating Cash Flow | 206.09 | 164.26 | 65.53 | 105.28 | 59.1 | 54.48 |
| Operating Cash Flow Growth | 176.54% | 150.66% | -37.75% | 78.14% | 8.48% | - |
| Capital Expenditures | -4.23 | -3.07 | -13.28 | -22.45 | -2.53 | -3.27 |
| Sale of Property, Plant & Equipment | 0 | - | - | - | 0.11 | - |
| Sale (Purchase) of Intangibles | -83.68 | -83.68 | -70.08 | -69.39 | -13.14 | -12.76 |
| Investment in Securities | -44.85 | 268.87 | -252.64 | 6.67 | 1.04 | - |
| Other Investing Activities | -50.81 | -70.81 | -70 | - | - | - |
| Investing Cash Flow | -183.56 | 111.32 | -406 | -85.17 | -8.46 | -13.07 |
| Long-Term Debt Repaid | - | -2.05 | -3.63 | -2.38 | -0.49 | -0.48 |
| Net Debt Issued (Repaid) | -2.05 | -2.05 | -3.63 | -2.38 | -0.49 | -0.48 |
| Issuance of Common Stock | - | - | 601.63 | 661.02 | - | - |
| Common Dividends Paid | - | - | - | -320 | - | - |
| Other Financing Activities | -0.1 | - | -20.2 | 333.58 | -47.47 | -41.38 |
| Financing Cash Flow | -2.15 | -2.05 | 577.8 | 672.23 | -47.96 | -41.86 |
| Foreign Exchange Rate Adjustments | -2.47 | -6.01 | -6.3 | 2.36 | - | - |
| Net Cash Flow | 17.91 | 267.52 | 231.04 | 694.69 | 2.67 | -0.46 |
| Free Cash Flow | 201.85 | 161.19 | 52.25 | 82.83 | 56.57 | 51.21 |
| Free Cash Flow Growth | 393.89% | 208.50% | -36.92% | 46.41% | 10.47% | - |
| Free Cash Flow Margin | 49.40% | 49.46% | 21.10% | 37.21% | 38.16% | 43.97% |
| Free Cash Flow Per Share | 0.58 | 0.46 | 0.16 | 0.27 | 0.20 | 0.18 |
| Cash Income Tax Paid | 28.84 | 26.57 | 4.72 | 0.52 | 14.11 | 6.51 |
| Levered Free Cash Flow | 285.72 | 26.85 | -707.51 | 646 | 21.54 | - |
| Unlevered Free Cash Flow | 285.84 | 26.98 | -695.65 | 653.22 | 21.55 | - |
| Change in Net Working Capital | -187.75 | 25.9 | 713.9 | -657.61 | 13.94 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.